248 related articles for article (PubMed ID: 19723116)
21. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
Reardon JT; Vaisman A; Chaney SG; Sancar A
Cancer Res; 1999 Aug; 59(16):3968-71. PubMed ID: 10463593
[TBL] [Abstract][Full Text] [Related]
22. The formation of DNA interstrand cross-links by a novel bis-[Pt2Cl4(diminazene aceturate)2]Cl4.4H2O complex inhibits the B to Z transition.
González VM; Fuertes MA; Jiménez-Ruíz A; Alonso C; Pérez JM
Mol Pharmacol; 1999 Apr; 55(4):770-7. PubMed ID: 10101036
[TBL] [Abstract][Full Text] [Related]
23. Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
Zák F; Turánek J; Kroutil A; Sova P; Mistr A; Poulová A; Mikolin P; Zák Z; Kasná A; Záluská D; Neca J; Sindlerová L; Kozubík A
J Med Chem; 2004 Jan; 47(3):761-3. PubMed ID: 14736257
[TBL] [Abstract][Full Text] [Related]
24. Cell death and DNA fragmentation induced by liposomal platinum(II) complex, L-NDDP in A2780 and A2780/PDD cells.
Han I; Ling YH; Khokhar AR; Perez-Soler R
Anticancer Res; 1994; 14(2A):421-6. PubMed ID: 8017841
[TBL] [Abstract][Full Text] [Related]
25. Relationship between DNA-reactivity and cytostatic effect of two novel bile acid-platinum derivatives, Bamet-UD2 and Bamet-D3.
Martinez-Diez MC; Larena MG; Serrano MA; Macias RI; Izco-Basurko I; Marin JJ
Anticancer Res; 2000; 20(5A):3315-21. PubMed ID: 11062759
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity and nephrotoxicity of a novel platinum complex, [1,3-bis(diphenylphosphino)propane](trans-1-dach)platinum(I I) dinitrate.
Baek MS; Rho YS; Jung JC; Chang SG; Nomura M; Miyamoto KJ
Anticancer Res; 1997; 17(2A):955-9. PubMed ID: 9137434
[TBL] [Abstract][Full Text] [Related]
27. Side-on binding of p-sulphonatocalix[4]arene to the dinuclear platinum complex trans-[{PtCl(NH3)2}2mu-dpzm]2+ and its implications for anticancer drug delivery.
Wheate NJ; Abbott GM; Tate RJ; Clements CJ; Edrada-Ebel R; Johnston BF
J Inorg Biochem; 2009 Mar; 103(3):448-54. PubMed ID: 19171382
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
Zhai X; Beckmann H; Jantzen HM; Essigmann JM
Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.
Mariggiò MA; Cafaggi S; Ottone M; Parodi B; Vannozzi MO; Mandys V; Viale M
Invest New Drugs; 2004 Jan; 22(1):3-16. PubMed ID: 14707490
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxicity of paclitaxel in combination with cisplatin and a new Pt-mercaptopyridine complex.
Ragazzi E; D'Ancona S; Berti E; Carrara M
Anticancer Res; 2002; 22(5):2783-8. PubMed ID: 12529997
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
32. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and preliminary evaluation of the new water-soluble radioactive platinum(IV) complexes.
Garnuszek P; Maurin M; Skierski JS; Koronkiewicz M; Witowska-Jarosz J
J Inorg Biochem; 2004 Mar; 98(3):553-9. PubMed ID: 14987857
[TBL] [Abstract][Full Text] [Related]
34. The interaction of DNA-targeted platinum phenanthridinium complexes with DNA in human cells.
Whittaker J; McFadyen WD; Baguley BC; Murray V
Anticancer Drug Des; 2001; 16(2-3):81-9. PubMed ID: 11962516
[TBL] [Abstract][Full Text] [Related]
35. Mutagenicity, cytotoxicity, and DNA binding of platinum(II)-chloroammines in Chinese hamster ovary cells.
Johnson NP; Hoeschele JD; Rahn RO; O'Neill JP; Hsie AW
Cancer Res; 1980 May; 40(5):1463-8. PubMed ID: 7189447
[TBL] [Abstract][Full Text] [Related]
36. [Apoptosis of K562 cell induced by N-phosphoryl dipeptide methyl ester].
Niu YL; Cao SL; Jiang YY; Du W; Zhao YF
Ai Zheng; 2002 Aug; 21(8):823-7. PubMed ID: 12478885
[TBL] [Abstract][Full Text] [Related]
37. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
[TBL] [Abstract][Full Text] [Related]
38. Recognition and repair of DNA-cisplatin adducts.
Woźniak K; Błasiak J
Acta Biochim Pol; 2002; 49(3):583-96. PubMed ID: 12422229
[TBL] [Abstract][Full Text] [Related]
39. [In vitro biological activity of new platinum(II) and palladium(II) complex compounds].
Malinowska K; Modranka R; Kubiak K; Mrowicka M; Kedziora J; Klimczak A; Rutkowski M
Pol Merkur Lekarski; 2009 Jan; 26(151):52-6. PubMed ID: 19391508
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic activity of sesquiterpenoids from Atractylodes ovata on leukemia cell lines.
Wang CC; Chen LG; Yang LL
Planta Med; 2002 Mar; 68(3):204-8. PubMed ID: 11914954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
